Duality Advisers’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,456
Closed -$215K 744
2023
Q2
$215K Buy
+8,456
New +$244K 0.03% 479
2022
Q2
Sell
-10,359
Closed -$749K 902
2022
Q1
$749K Buy
10,359
+972
+10% +$70.1K 0.08% 395
2021
Q4
$761K Sell
9,387
-5,511
-37% -$552K 0.08% 342
2021
Q3
$1.73M Buy
+14,898
New +$1.95M 0.13% 268
2021
Q2
Sell
-18,594
Closed -$2.59M 755
2021
Q1
$2.59M Buy
18,594
+17,054
+1,107% +$2.78M 0.23% 147
2020
Q4
$267K Buy
+1,540
New +$249K 0.02% 504

Other funds holding NVRO

Duality Advisers's NVRO Position: Q3 2023 in Review

Duality Advisers sold out of NEVRO CORP. (NVRO) in Q3 2023, closing a stake of 8,456 shares — an estimated $215K sold.

Duality Advisers first reported a position in NVRO in Q4 2020 and held it in 6 quarters. The position peaked at $2.59M in Q1 2021. 136 funds tracked by Wall St. Rank hold NVRO as of Q3 2023.

  • Duality Advisers reported no remaining NEVRO CORP. position as of Q3 2023 after selling out during the quarter.
  • Duality Advisers sold 8,456 NEVRO CORP. shares in Q3 2023, an estimated $215K.
  • Duality Advisers first reported a position in NEVRO CORP. in Q4 2020 and held it in 6 quarters.
  • Duality Advisers's NEVRO CORP. position peaked at $2.59M in Q1 2021.
  • 136 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2023.

Based on Duality Advisers's 13F filing for Q3 2023, filed 2 Nov 2023.